{"id":"https://openalex.org/W3211925247","doi":"https://doi.org/10.1182/blood-2021-152897","title":"Characteristics and Outcomes of Adult Patients with Malignancy-Associated Hemophagocytic Lymphohistiocytosis: A Single-Center, Prospective Analysis","display_name":"Characteristics and Outcomes of Adult Patients with Malignancy-Associated Hemophagocytic Lymphohistiocytosis: A Single-Center, Prospective Analysis","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3211925247","doi":"https://doi.org/10.1182/blood-2021-152897","mag":"3211925247"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-152897","doi":"https://doi.org/10.1182/blood-2021-152897","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-152897","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060733811","display_name":"Shehab Mohamed","orcid":"https://orcid.org/0000-0002-3157-3720","observed_orcids":["https://orcid.org/0000-0002-3157-3720"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shehab Fareed Mohamed","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069285537","display_name":"Rita Elias Assi","orcid":"https://orcid.org/0000-0003-0046-7113","observed_orcids":["https://orcid.org/0000-0003-0046-7113","https://orcid.org/0000-0003-1159-883X"]},"institutions":[{"id":"https://openalex.org/I98635879","display_name":"American University of Beirut","ror":"https://ror.org/04pznsd21","country_code":"LB","type":"education","lineage":["https://openalex.org/I98635879"]}],"countries":["LB"],"is_corresponding":false,"raw_author_name":"Rita Assi","raw_affiliation_strings":["AUB, Beirut, Lebanon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AUB, Beirut, Lebanon","institution_ids":["https://openalex.org/I98635879"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006858509","display_name":"Jing Ning","orcid":"https://orcid.org/0000-0002-5289-331X","observed_orcids":["https://orcid.org/0000-0002-5289-331X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Ning","raw_affiliation_strings":["department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067227071","display_name":"Lianchun Xiao","orcid":"https://orcid.org/0000-0003-0972-2766","observed_orcids":["https://orcid.org/0000-0003-0972-2766"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lianchun Xiao","raw_affiliation_strings":["department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias J. Jabbour","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":["Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan M. Kadia","raw_affiliation_strings":["Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050041791","display_name":"Musa E. Yilmaz","orcid":"https://orcid.org/0000-0002-4498-4895","observed_orcids":["https://orcid.org/0000-0002-4498-4895","https://orcid.org/0000-0001-9557-678X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Musa Yilmaz","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075581944","display_name":"Abhishek Maiti","orcid":"https://orcid.org/0000-0001-9043-538X","observed_orcids":["https://orcid.org/0000-0001-9043-538X"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhishek Maiti","raw_affiliation_strings":["Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059600583","display_name":"Ghayas C. Issa","orcid":"https://orcid.org/0000-0002-4339-8683","observed_orcids":["https://orcid.org/0000-0002-4339-8683"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ghayas C. Issa","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013173470","display_name":"Prithviraj Bose","orcid":"https://orcid.org/0000-0002-4343-5712","observed_orcids":["https://orcid.org/0000-0002-4343-5712"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prithviraj Bose","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080350639","display_name":"Lucia Mas\u00e1rov\u00e1","orcid":"https://orcid.org/0000-0001-6624-4196","observed_orcids":["https://orcid.org/0000-0001-6624-4196"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucia Masarova","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"1213","last_page":"1213"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hlh-2004-criteria","display_name":"HLH-2004 criteria","score":0.9150000214576721},{"id":"https://openalex.org/keywords/serum-ferritin","display_name":"serum ferritin","score":0.7490000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6330000162124634},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4830000102519989},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.42800000309944153},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.6140000224113464},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.8840000033378601},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.6790000200271606},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.41999998688697815},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C2779079688","wikidata":"https://www.wikidata.org/wiki/Q1642170","display_name":"Hemophagocytic lymphohistiocytosis","level":3,"score":0.7930576801300049},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6945711970329285},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.6806647181510925},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.5309065580368042},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.5126723051071167},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4206744432449341},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2940353751182556},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22520336508750916},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09934279322624207}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-152897","doi":"https://doi.org/10.1182/blood-2021-152897","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-152897","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4229026038","https://openalex.org/W2789991172","https://openalex.org/W4226095060","https://openalex.org/W4295927595","https://openalex.org/W4361305481","https://openalex.org/W2048982951","https://openalex.org/W2550221398","https://openalex.org/W2620052751","https://openalex.org/W2763006076","https://openalex.org/W2901309864"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Hemophagocytic":[2],"lymphohistiocytosis":[3],"(HLH)":[4],"is":[5,19],"a":[6,101,280,506,526,581,632,637,654,664,1033,1080],"life-threatening":[7],"syndrome":[8],"characterized":[9],"by":[10,27],"sustained":[11],"immune":[12,35],"overactivation":[13],"and":[14,114,126,146,192,212,243,257,264,294,307,324,361,399,424,433,448,470,576,621,662,680,696,706],"dysregulation.":[15],"Malignancy-associated":[16],"HLH":[17,131,166,176,209,227,253,277,694],"(M-HLH)":[18],"associated":[20,579],"with":[21,61,98,100,190,208,279,427,446,453,490,495,525,536,548,555,562,570,580,595,598,636,648,675,677,682],"particularly":[22],"dismal":[23],"outcomes,":[24],"likely":[25],"perpetuated":[26],"inflammation":[28],"from":[29,161],"neoplastic":[30],"cells,":[31],"as":[32],"well":[33],"dysfunctional":[34],"regulation":[36],"secondary":[37],"to":[38,89,165,614,701],"the":[39,83,129,250,336,350,353,457,478,500,516,615],"underlying":[40,63,84,120],"malignancy":[41,65,121,136,140],"and/or":[42,385],"chemotherapy,":[43],"infection,":[44],"immunotherapies,":[45],"or":[46,148,487,649,740,759,773,804,851,877,1043,1058,1216,1249],"hematopoietic":[47],"stem":[48],"cell":[49],"transplantation.":[50],"Methods:":[51],"We":[52,416],"retrospectively":[53],"reviewed":[54],"patients":[55,297,593,673],"(pts)":[56],"aged":[57],"\u2265":[58],"18":[59,377,392,479],"years":[60,106],"an":[62,178,735,754,768,799,846,872,1038,1053,1211,1244],"hematological":[64],"(HM)":[66],"who":[67,421,429,481],"fulfilled":[68,226],"\u22655":[69],"HLH-2004":[70],"criteria":[71,228],"at":[72,276,311,333,340,367],"our":[73,644],"institution":[74],"between":[75],"2011":[76],"-":[77,174,286,322,347,514],"2020.":[78],"High":[79],"risk":[80,583],"disease":[81,635],"for":[82,201],"HM":[85,164,182,218,437],"was":[86,122,132,168,219,233,317,342,356,371,389,411,438,520,578,590,670],"defined":[87],"according":[88],"WHO":[90],"Risk":[91],"stratifications.":[92],"Results:":[93],"Forty-seven":[94],"pts":[95,195,205,232,239,270,328,420,444,480,502,661],"were":[96,112,116,206,259,400],"diagnosed":[97,133,189,207],"M-HLH":[99,630],"median":[102,158,223,507],"age":[103],"of":[104,163,181,225,252,282,326,376,394,419,442,477,492,499,509,530,584,609,619,625,660,691,738,757,771,795,802,849,875,1029,1041,1056,1214,1247],"61":[105],"(range,":[107,172,235,284,320,345,359],"19-81),":[108],"32":[109],"(68.1":[110],"%)":[111],"male,":[113],"most":[115,407],"Caucasian":[117],"(87.3%).":[118],"The":[119,157,222,406,588,668,689],"myeloid":[123],"in":[124,128,137,141,143,151,183,220,229,261,373,391,402,440,449,592,623,656,672,1032],"70%":[125],"lymphoid":[127,537,678],"rest.":[130],"during":[134,147],"active":[135],"33":[138,237],"(70%),":[139],"remission":[142],"four":[144],"(8%),":[145],"after":[149],"relapse":[150],"10":[152],"(21%)":[153],"pts.":[154,379,395],"Table":[155,396,627],"1":[156,710],"(med)":[159],"time":[160,251],"diagnosis":[162,180,278,341],"manifestations":[167],"7.5":[169],"months":[170],"(m)":[171],"0":[173],"177).":[175],"preceded":[177],"overt":[179],"4":[184,187],"cases":[185],"(all":[186],"eventually":[188],"AML":[191],"MDS).":[193],"Forty":[194],"(85%)":[196],"had":[197,271,298,329,363,463,468,484,539,551,565,606],"received":[198,422,430,482],"prior":[199],"treatment":[200],"their":[202,217],"HM.":[203],"Three":[204],"2.0m,":[210],"4.0m,":[211],"7.5m":[213],"following":[214],"ASCT,":[215],"while":[216],"remission.":[221],"number":[224],"these":[230],"47":[231,458,501],"6":[234],"5-8):":[236],"(71%)":[238],"met":[240,246],"5-6":[241],"variables":[242],"14":[244,292],"(29%)":[245],"7-8":[247],"criteria.":[248],"At":[249],"diagnosis,":[254],"high-grade":[255],"fever":[256],"splenomegaly":[258],"present":[260],"44":[262],"(93%)":[263],"27":[265,346],"(57%)":[266],"pts,":[267,460],"respectively.":[268],"All":[269],"serum":[272,299,331],"ferritin":[273,300,563,572,683],">500":[274],"ng/mL":[275],"med":[281,518],"56,707ng/mL":[283],"3,059":[285],"47,1540);":[287],"30":[288],"(76.5%),":[289],"24":[290],"(51%),":[291],"(29%),":[293],"9":[295],"(20%)":[296],">10,000":[301],"ng/mL,":[302,304,306,309],">25,000":[303],">50,000":[305],">100,000":[308],"respectively":[310],"diagnosis.":[312,334,368],"Serum":[313],"triglyceride":[314],"(TG)":[315],"level":[316,339,355,684],"318":[318],"mg/dL":[319,344],"8.6":[321],"971)":[323],"64%":[325],"evaluable":[327],"elevated":[330,364],"TG":[332,995],"Similarly,":[335],"plasma":[337],"fibrinogen":[338],"241":[343],"702).":[348],"Of":[349,456],"32-pts":[351],"tested,":[352],"sIL2r":[354,365],"7010":[357],"U/mL":[358],"749-127,000)":[360],"72%":[362],"levels":[366],"NK":[369],"function":[370],"decreased":[372],"12":[374],"(66.6%)":[375],"evaluated":[378],"Based":[380],"on":[381,734,753,767,798,845,871,1037,1052,1210,1243],"bone":[382],"marrow,":[383],"spleen,":[384],"liver":[386],"assessments,":[387],"hemophagocytosis":[388],"seen":[390],"(43%)":[393],"2Mutation":[397],"panels":[398],"negative":[401],"(15":[403],"patients,":[404],"31.9%).":[405],"common":[408],"mutation":[409],"identified":[410],"TP53":[412],"(7,":[413],"14.9%)":[414],"patients.":[415],"compared":[417,489,554,597],"outcomes":[418],"etoposide":[423],"dexamethasone":[425],"(DE)":[426,447],"those":[428,569,681],"etoposide,":[431],"dexamethasone,":[432],"tocilizumab":[434],"(DET.)":[435],"High-risk":[436],"observed":[439],"13":[441],"17":[443],"treated":[445,452,459,494,594,674],"all":[450],"19-pts":[451],"(DET)":[454],"(P=0.02).":[455],"seven":[461],"(14.9%)":[462],"complete":[464],"response,":[465],"nine":[466],"(19%)":[467],"PR":[469],"31":[471],"(66%)":[472],"did":[473],"not":[474],"respond.":[475],"Eight":[476],"DE":[483,596],"either":[485],"CR":[486],"PR,":[488],"five":[491],"19":[493],"DET":[496,604],"(P=0.3133).":[497],"Thirty-eight":[498],"have":[503],"died.":[504],"With":[505],"follow-up":[508],"8.8m":[510],"(95%":[511,522,532,557,573],"CI,":[512,523,533,558],"4.43":[513],"NR),":[515],"estimated":[517],"OS":[519,541,553,567,589,669],"0.95m":[521],"0.59-3.25)":[524],"1-year":[527,638],"survival":[528,639],"probability":[529],"16.6%":[531],"7.91%-34.6%.":[534],"Patients":[535],"malignancies":[538,679],"improved":[540,552,666,671],"(95%CI,":[542],"0.1865-0.9092,":[543],"P=0.027,)":[544],"Fig":[545,602],"1.":[546,712],"Pts":[547,561],"CR/PR":[549],"response":[550,655,665],"non-responders":[556],"0.1377-0.6664)":[559],"P=0.03).":[560],"<50,000":[564],"better":[566],"than":[568,686],"higher":[571,582,591,607],"1.0245-4,004,":[574],"P=_0.04_)":[575],"IL_10":[577],"death":[585],"(HR=1.0008,":[586],"p=0.0443).":[587],"DET,":[599],"(95%CI,1.1407-5.3375,":[600],"P=0.02)":[601],"2.":[603],"group":[605],"proportion":[608],"high-risk":[610],"disease,":[611],"admitted":[612],"more":[613,617],"ICU,":[616],"use":[618],"pressor":[620],"increase":[622],"length":[624],"stay.":[626],"3":[628],"Conclusion":[629],"remains":[631],"highly":[633],"fatal":[634],"<20%":[640],"despite":[641],"therapy.":[642],"In":[643],"report,":[645],"etoposide-based":[646],"therapies":[647],"without":[650],"malignancy-directed":[651],"therapy":[652],"induced":[653],"only":[657],"about":[658],"35%":[659],"achieving":[663],"survival.":[667],"(DE),":[676],"less":[685],"50,000":[687],"(P=0.04).":[688],"implementation":[690],"adult":[692],"specific":[693],"programs":[695],"multidisciplinary":[697],"collaboration":[698],"are":[699],"required":[700],"foster":[702],"directed":[703],"clinical":[704],"guidelines":[705],"improve":[707],"outcomes.":[708],"Figure":[709,711],"Disclosures":[713],"Jabbour:":[714],"Amgen,":[715],"AbbVie,":[716],"Spectrum,":[717],"BMS,":[718],"Takeda,":[719],"Pfizer,":[720],"Adaptive,":[721],"Genentech:":[722,905,954],"Research":[723,745,784,788,811,817,819,836,855,881,952,956,961,965,973,977,981,986,989,993,1001,1004,1010,1013,1021,1048,1065,1069,1073,1077,1086,1090,1093,1099,1103,1107,1120,1125,1133,1136,1139,1145,1150,1155,1158,1165,1170,1175,1180,1185,1189,1195,1201,1205,1219,1223,1227,1230,1236,1252],"Funding.":[724,1014,1087,1094,1108,1181,1253],"Pemmaraju:":[725],"Sager":[726],"Strong":[727],"Foundation:":[728],"Other;":[729,781,792,904,913,915,940,944,946],"ASH":[730],"Communications":[731],"Committee:":[732],"Membership":[733,752,766,797,844,870,1036,1051,1209,1242],"entity's":[736,755,769,800,847,873,1039,1054,1212,1245],"Board":[737,756,770,801,848,874,1040,1055,1213,1246],"Directors":[739,758,772,803,850,876,1042,1057,1215,1248],"advisory":[741,760,774,805,852,878,1044,1059,1217,1250],"committees;":[742,761,775,806,1045,1060],"Plexxicon:":[743],"Other,":[744,783,810,835,854,880],"Funding;":[746,785,789,812,820,837,856,882,953,957,962,966,974,978,982,987,990,994,1002,1005,1011,1022,1049,1066,1070,1074,1078,1091,1100,1104,1121,1126,1134,1137,1140,1146,1151,1156,1159,1166,1171,1176,1186,1190,1196,1202,1206,1220,1224,1228,1231,1237],"Incyte:":[747,988],"Consultancy;":[748,824,827,831,840,859,862,865,885,888,892,895,911,918,920,922,932,942,1113,1116,1118],"HemOnc":[749],"Times/Oncology":[750],"Times:":[751],"ASCO":[762],"Leukemia":[763],"Advisory":[764],"Panel:":[765],"Springer":[776],"Science":[777],"+":[778],"Business":[779],"Media:":[780],"Samus:":[782],"Affymetrix:":[786],"Consultancy,":[787,791,815,843,869,906,934,939,1019,1047,1098,1102,1124,1128,1234],"MustangBio:":[790],"Dan's":[793],"House":[794],"Hope:":[796],"Daiichi":[807],"Sankyo,":[808],"Inc.:":[809,823,868,884],"Novartis":[813],"Pharmaceuticals:":[814,842,897,1106,1115,1144,1233],"Other:":[816,907,924,928,935],"Support,":[818],"Protagonist":[821],"Therapeutics,":[822,867],"Roche":[825],"Diagnostics:":[826],"Clearview":[828],"Healthcare":[829],"Partners:":[830],"Cellectis":[832],"S.A.":[833],"ADR:":[834],"LFB":[838],"Biotechnologies:":[839,959],"Abbvie":[841],"committees,":[853,879,1218,1251],"Aptitude":[857],"Health:":[858],"Celgene":[860,1152],"Corporation:":[861,1153,1178],"DAVA":[863],"Oncology:":[864,1097,1123,1161],"Stemline":[866],"CareDx,":[883],"Blueprint":[886,1172],"Medicines:":[887,1173],"Bristol-Myers":[889],"Squibb":[890,1083],"Co.:":[891],"ImmunoGen,":[893],"Inc:":[894],"Pacylex":[896],"Consultancy.":[898],"Kadia:":[899],"Cure:":[900],"Speakers":[901],"Bureau;":[902],"AstraZeneca:":[903,979,1117,1191],"Grant/research":[908,925,929,936],"support;":[909,926,930,937],"Sanofi-Aventis:":[910],"Ascentage:":[912],"Genfleet:":[914],"Dalichi":[916],"Sankyo:":[917],"Liberum:":[919],"Jazz:":[921,1203],"BMS:":[923,1131],"Amgen:":[927,1127,1225],"Aglos:":[931],"AbbVie:":[933,1008,1046,1193],"Pfizer:":[938,1003,1092,1135],"Novartis:":[941,1023,1101,1110,1141,1197],"Pulmotech:":[943],"Cellonkos:":[945],"Astellas:":[947,1119,1138],"Other.":[948],"Jain:":[949],"Fate":[950],"Therapeutics:":[951,964,984,996,1148],"Honoraria,":[955,960,972,976,980,985,992,1000,1009,1020,1064,1068,1072,1076,1085,1132,1149,1154,1169,1174,1179,1184,1188,1194,1200,1204,1208,1222,1226,1235,1241],"Adaptive":[958],"Aprea":[963],"Beigene:":[967],"Honoraria;":[968,997,1007,1017,1024,1111,1142,1162,1192,1198],"Bristol":[969,1061,1081,1238],"Myers":[970,1062,1082,1239],"Squibb:":[971,1063,1240],"Servier:":[975],"ADC":[983],"Cellectis:":[991],"Precision":[998],"Biosciences:":[999],"Janssen:":[1006],"Pharmacyclics:":[1012],"DiNardo:":[1015],"Takeda:":[1016],"Agios/Servier:":[1018],"Notable":[1025],"Labs:":[1026],"Current":[1027],"holder":[1028],"stock":[1030],"options":[1031],"privately-held":[1034],"company,":[1035],"GlaxoSmithKline:":[1050],"ImmuneOnc:":[1067],"Forma:":[1071],"Foghorn:":[1075],"Celgene,":[1079],"company:":[1084],"Yilmaz:":[1088],"Daiichi-Sankyo:":[1089],"Issa:":[1095],"Kura":[1096],"Syndax":[1105],"Short:":[1109],"NGMBio:":[1112],"Jazz":[1114],"Takeda":[1122],"Honoraria.":[1129],"Bose:":[1130],"Constellation":[1143],"Kartos":[1147],"Promedior:":[1157],"Sierra":[1160],"NS":[1163],"Pharma:":[1164],"CTI":[1167],"BioPharma:":[1168],"Incyte":[1177],"Ravandi:":[1182],"Astex:":[1183],"Agios:":[1187],"Taiho:":[1199],"Celgene:":[1207],"Xencor:":[1221],"Prelude:":[1229],"Syros":[1232],"Kon":[1254]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}